Action Point Financial Planning’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Action Point Financial Planning's PRAX Position: Q3 2026 in Review
Action Point Financial Planning sold out of Praxis Precision Medicines (PRAX) in Q3 2026, closing a stake of 3 shares — an estimated $1K sold.
Action Point Financial Planning first reported a position in PRAX in Q2 2026 and held it in 1 quarter. The position peaked at $1K in Q2 2026. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Action Point Financial Planning reported no remaining Praxis Precision Medicines position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 3 Praxis Precision Medicines shares in Q3 2026, an estimated $1K.
- Action Point Financial Planning first reported a position in Praxis Precision Medicines in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Praxis Precision Medicines position peaked at $1K in Q2 2026.
- 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.